Innospec Inc. (NASDAQ:IOSP) Shares Bought by AlphaMark Advisors LLC

AlphaMark Advisors LLC lifted its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 19.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,036 shares of the specialty chemicals company’s stock after acquiring an additional 488 shares during the quarter. AlphaMark Advisors LLC’s holdings in Innospec were worth $343,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in IOSP. DekaBank Deutsche Girozentrale acquired a new position in shares of Innospec during the first quarter worth about $66,000. CWM LLC lifted its position in Innospec by 239.6% during the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock worth $78,000 after acquiring an additional 448 shares in the last quarter. nVerses Capital LLC boosted its holdings in Innospec by 200.0% in the 3rd quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 600 shares during the period. Motco acquired a new stake in Innospec in the first quarter valued at approximately $132,000. Finally, EntryPoint Capital LLC purchased a new stake in shares of Innospec during the first quarter valued at approximately $147,000. 96.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Innospec Stock Performance

Shares of NASDAQ IOSP opened at $113.31 on Friday. Innospec Inc. has a 1 year low of $95.69 and a 1 year high of $133.71. The stock’s 50-day simple moving average is $111.26 and its 200-day simple moving average is $119.99. The firm has a market cap of $2.83 billion, a price-to-earnings ratio of 18.98 and a beta of 1.07.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.02. The company had revenue of $435.00 million for the quarter, compared to the consensus estimate of $468.73 million. Innospec had a return on equity of 14.15% and a net margin of 7.90%. Innospec’s revenue for the quarter was down 9.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.28 EPS. As a group, research analysts predict that Innospec Inc. will post 5.95 EPS for the current year.

Insider Activity at Innospec

In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $114.74, for a total transaction of $389,886.52. Following the completion of the transaction, the chief financial officer now directly owns 12,996 shares of the company’s stock, valued at $1,491,161.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.35% of the stock is currently owned by corporate insiders.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.